Syneron Medical Ltd. Fund Company Profile

Description

Syneron Medical Ltd., together with its subsidiaries, researches, develops, manufactures, markets, and sells aesthetic medical products worldwide. The company develops products based on its proprietary Electro-Optical Synergy technology, which uses the synergy between electrical energy and optical energy to provide aesthetic medical treatments. It offers products, which are used for various non-invasive aesthetic medical procedures, including hair removal, wrinkle reduction, rejuvenation of the skin’s appearance through the treatment of superficial benign vascular and pigmented lesions, acne treatment, treatment of leg veins, treatment for the temporary reduction in the appearance of cellulite and thigh circumference, ablation and resurfacing of the skin, laser-assisted lipolysis, and tattoo removal. The company also provides cosmetic and aesthetic lasers, and light-based systems used by physicians and personal care practitioners; non-invasive technologies for fat cell destruction and body sculpting; Viador system, a handheld device with a radiofrequency-needle array for use in transdermal delivery of biologic drug-products through a system-specific skin patch. It sells its products to dermatologists, plastic surgeons, other cosmetic physicians, qualified practitioners, and aestheticians and medical spas through direct sales force and distributors; and directly to end-users. Syneron Medical Ltd. was founded in 2000 and is headquartered in Yokneam Illit, Israel.